Skip to main content
Clinical Trials/NCT05780411
NCT05780411
Not Yet Recruiting
N/A

A Comprehensive Study of Cancer Survivor Syndrome in Adult Egyptian Patients With Hematological Neoplasms

Assiut University1 site in 1 country80 target enrollmentApril 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cancer Survivors
Sponsor
Assiut University
Enrollment
80
Locations
1
Primary Endpoint
The incidence of cancer survivor syndrome (CSS)
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

General objective: to improve care for haematological cancer survivors. This study will (i) Estimate the incidence of cancer survivor syndrome (CSS) in adult Egyptian patients with haematological neoplasms (HN). (ii) Asses the risk factors of CSS in patients with HN. (iii) Study the effect of CSS on quality of life in patients with HN. (iv) To explore coping strategies of patients with HN having CSS

Detailed Description

According to the American Cancer Society the term cancer survivor refersto people who have no signs of cancer after finishing treatment, people receiving extended treatment over a longer period of time to control the cancer or reduce risk of its return, and people with advanced cancer. Most hematologic malignancies (HM) are incurable and typically follow unpredictable remitting-relapsing pathways associated with varying need for treatment, which may be distressing for patients. Distress symptoms and psychological disorders secondary to cancer have also been shown to have significant negative consequences for both the patient and the family. Maladaptive coping and abnormal illness behavior have been associated with psychiatric conditions, with negative effects on adherence to treatment, health behavior, and quality of life (Grassi et al 2017). Moreover, an increased length of stay in the hospital and/or an increased time in rehabilitation have been found to be more common among patients showing psychiatric symptoms, especially depression, than those with normal adjustment to illness (Cordova et al 2017). Unfortunately, cancer-related distress is commonly underrecognized and subsequently undertreated especially for patients with HM in developing countries. Search in literature revealed several screening methods for the psychological consequences of cancer such as Distress Thermometer , Symptom related checklist questionnaire, Quality of life questionnaire, Coping strategies questionnaire. Also, guidelines for the management of psychological distress have been developed by several scientific cancer associations.

Registry
clinicaltrials.gov
Start Date
April 1, 2023
End Date
March 31, 2025
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Roaa Mohammed Mohammed Saleh

Resident Physician

Assiut University

Eligibility Criteria

Inclusion Criteria

  • a. Inclusion criteria:
  • Age will be more than or equal 18 years old regardless with six.
  • Patients have been clinically diagnosed with haematological cancers.
  • Being Native Egyptian patients.

Exclusion Criteria

  • History of psychiatric disorders. b) Having other concomitant haematological diseases or solid neoplasm or relapse or other chronic disorders

Outcomes

Primary Outcomes

The incidence of cancer survivor syndrome (CSS)

Time Frame: 2 years

Estimate the incidence of cancer survivor syndrome (CSS) in adult Egyptian patients with hematological neoplasm neoplasms (HN)

Secondary Outcomes

  • Study the effect of CSS on quality of life(2 years)
  • Asses the risk factors of CSS(2 years)
  • Exploring coping strategies(2 years)

Study Sites (1)

Loading locations...

Similar Trials